Foldyne Research International
Foldyne Research International delivers advanced molecular modeling services in the field of structure-based drug design by creating dynamic protein models and by deriving functional insights, needed to speed up drug discovery processes of pharmaceutical companies. Our corporate-developed modeling technology enables the company to design compounds specifically for personalized medicine and precision medicine for orphan diseases. Developing life-saving cures for rare indications is challenging because of low budget availability. Limited revenue expectation due to small patient groups requires zero attrition rates in the pharmaceutical value chain. Currently, our modeling technology allows the fastest development of the best binding compounds and simultaneous optimization of drug-like properties. These include binding to drug transporters and avoiding toxic anti-targets.